↓ Skip to main content

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

Overview of attention for article published in Diabetologia, August 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
3 news outlets
policy
1 policy source
patent
48 patents

Citations

dimensions_citation
710 Dimensions

Readers on

mendeley
350 Mendeley
citeulike
1 CiteULike
Title
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
Published in
Diabetologia, August 2009
DOI 10.1007/s00125-009-1472-y
Pubmed ID
Authors

D. Russell-Jones, A. Vaag, O. Schmitz, B. K. Sethi, N. Lalic, S. Antic, M. Zdravkovic, G. M. Ravn, R. Simó, on behalf of the Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Study Group

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 350 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 <1%
Denmark 2 <1%
Japan 2 <1%
Brazil 2 <1%
Uruguay 1 <1%
South Africa 1 <1%
Netherlands 1 <1%
Canada 1 <1%
France 1 <1%
Other 2 <1%
Unknown 334 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 66 19%
Student > Master 56 16%
Other 35 10%
Student > Ph. D. Student 34 10%
Student > Postgraduate 28 8%
Other 70 20%
Unknown 61 17%
Readers by discipline Count As %
Medicine and Dentistry 174 50%
Pharmacology, Toxicology and Pharmaceutical Science 26 7%
Agricultural and Biological Sciences 25 7%
Biochemistry, Genetics and Molecular Biology 10 3%
Nursing and Health Professions 7 2%
Other 36 10%
Unknown 72 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2024.
All research outputs
#1,339,812
of 24,552,012 outputs
Outputs from Diabetologia
#734
of 5,272 outputs
Outputs of similar age
#4,003
of 117,535 outputs
Outputs of similar age from Diabetologia
#5
of 46 outputs
Altmetric has tracked 24,552,012 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,272 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.3. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 117,535 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.